• Artivion Inc AORT.N reported a quarterly adjusted loss of 1 cent​​ per share for the quarter ended March 31, lower than the same quarter last year, when the company reported EPS of 6 cents. The mean expectation of six analysts for the quarter was for a loss of 12 cents per share. Wall Street expected results to range from -22 cents to -2 cents per share.

• Revenue rose 1.6% to $98.98 million from a year ago; analysts expected $94.99 million.

• Artivion Inc's reported EPS for the quarter was a loss of 1 cent​.

• The company reported a quarterly loss of $505 thousand.

• Artivion Inc shares had fallen by 5.1% this quarter and lost 18.4% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 425.9% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 6 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy."

• Wall Street's median 12-month price target for Artivion Inc is $32.00

This summary was machine generated from LSEG data May 5 at 09:02 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)